LEXICON PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/32fc79fd-5ca5-46ed-971c-9e4f3f4fcaae/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-48.9M | 2025-01-01 – 2025-12-31 | evidence 0001062822-26-000050 |
| FY 2024 | $-197.1M | 2024-01-01 – 2024-12-31 | evidence 0001062822-25-000013 |
| FY 2023 | $-171.8M | 2023-01-01 – 2023-12-31 | evidence 0001062822-24-000008 |
| FY 2022 | $-100.8M | 2022-01-01 – 2022-12-31 | evidence 0001062822-23-000007 |
| FY 2021 | $-87.1M | 2021-01-01 – 2021-12-31 | evidence 0001062822-22-000005 |
| FY 2020 | $-47.8M | 2020-01-01 – 2020-12-31 | evidence 0001062822-21-000013 |
| FY 2019 | $141.4M | 2019-01-01 – 2019-12-31 | evidence 0001062822-20-000015 |
| FY 2018 | $-103.3M | 2018-01-01 – 2018-12-31 | evidence 0001062822-19-000007 |
| FY 2017 | $-130.6M | 2017-01-01 – 2017-12-31 | evidence 0001062822-19-000007 |
| FY 2016 | $-127.2M | 2016-01-01 – 2016-12-31 | evidence 0001062822-19-000007 |
| FY 2015 | $1.5M | 2015-01-01 – 2015-12-31 | evidence 0001062822-16-000051 |
| FY 2014 | $-100.4M | 2014-01-01 – 2014-12-31 | evidence 0001062822-15-000013 |
| FY 2013 | $-102.4M | 2013-01-01 – 2013-12-31 | evidence 0001062822-14-000009 |
| FY 2012 | $-108.4M | 2012-01-01 – 2012-12-31 | evidence 0001062822-13-000008 |
| FY 2011 | $-114.1M | 2011-01-01 – 2011-12-31 | evidence 0001062822-12-000010 |
| FY 2010 | $-95.7M | 2010-01-01 – 2010-12-31 | evidence 0001062822-12-000010 |
| FY 2009 | $-90.0M | 2009-01-01 – 2009-12-31 | evidence 0001062822-12-000010 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
LEXICON PHARMACEUTICALS, INC. — all facts · Revenue · Net Income